Hims & Hers CFO Okupe Oluyemi Exercises Options, Sells Shares

What Happened

• Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, exercised 4,938 stock options and sold those 4,938 shares on August 19, 2026. The options were exercised at $5.01 per share (cost $24,739) and the shares were sold in an open-market sale at an average weighted price of $29.99 per share, generating proceeds of $148,111 (net pre-tax gain ≈ $123,372). The filing also records a derivative disposition at $0, which reflects the conversion/exercise of the options.

Key Details

• Transaction date: 2026-08-19 (Filed: 2026-08-20)
• Exercise: 4,938 shares @ $5.01 — total cost $24,739
• Sale: 4,938 shares @ avg. $29.99 — total proceeds $148,111; sale prices ranged $29.95–$30.045 (weighted avg reported)
• Shares owned after transaction: Not disclosed in the provided excerpt
• Footnotes: Transactions were executed under a Rule 10b5-1 trading plan adopted May 21, 2025 (F1). Price is an average weighted price; detailed per-price breakdown available on request (F2). Vesting schedule for options described (F3).
• Timeliness: Filing was submitted the day after the transaction (appears timely)

Context

• This was an option exercise followed by an immediate sale of the resulting shares — effectively a cashless exercise where the insider converts options to shares and sells them the same day. The sale was carried out under a pre-established 10b5-1 plan, which is commonly used to automate insider sales and reduce questions about trading intent. No inference about the company’s prospects should be drawn solely from this routine, plan-based transaction.